Episode 028: World Cancer Day

The Syneos Health Podcast

The treatment of cancer has undergone a sea change in the span of a generation. In this two-part episode for World Cancer Day, we discuss the increasingly complex oncology landscape, from both a clinical and clinician perspective.

First, Bob Millham, Executive Vice President of Clinical Development and head of our Oncology Center of Excellence, addresses the potential of clinical research in driving toward a world where cancer is treated more like a chronic condition than a death sentence – and the ongoing, critical importance of engaging patients in the process.

We then hear from Dave Querry, President of The Navicor Group, on the evolving role of the oncologist and how manufacturers need to think about engaging differently with this increasingly specialized practitioner.

Interested in reading more? Follow these links for a deeper dive into a broad range of oncology topics from these and other Syneos Health experts:

Trends In Oncology Trial Terminations Due To Toxicity

ESMO 2018 Congress: Some Good Answers and Quite a Few New Questions

Pursuing Accelerated Approval in Oncology Indications

The Importance of Real World Evidence in Oncology

BIO18: Oncology Surplus Could Drive Down Values

A New Reality for Small Oncology Trial Sites: A Need to Adopt a Federated Approach?

The views expressed in this podcast belong solely to the speakers and do not represent those of their organization.
If you want access to more future-focused, actionable insights to help biopharmaceutical companies better execute and succeed in a constantly evolving environment, visit the Syneos Health Insights Hub. The perspectives you’ll find there are driven by dynamic research and crafted by subject matter experts focused on real answers to help guide decision-making and investment. You can find it all at insightshub.health.
Like what you’re hearing? Be sure to rate and review us!
We want to hear from you! If there’s a topic you’d like us to cover on a future episode, contact us at [e-mail].